Cargando...

Targeting B cells for the treatment of SLE: The beginning of the end or the end of the beginning?

Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease for which therapeutic advances in immunosuppressive and support therapy have significantly improved survival over the last 5 decades. Unfortunately, SLE still carries substantially increased rates of mortality and end stage renal di...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Discov Med
Autores principales: Calero, Ismael, Sanz, Iñaki
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4557964/
https://ncbi.nlm.nih.gov/pubmed/21122473
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!